News Breaks |
|
|
| March 13, 2013 |
| 07:09 EDT |  | ABT | Abbott management to meet with UBS
Meeting to be held in the Southeast on March 13 hosted by UBS. |
|
|
News For ABT From The Last 14 Days Check below for free stories on ABT the last two weeks. |
|
|
| May 23, 2013 |
| 08:14 EDT | | ABT | Carter's
Global Consumer Products Analysts discuss the possibility of China retiring the one-child policy within the year and potential implications for consumer products on an Analyst/Industry conference call. Relevant covered companies JNJ, PG, PFE, ABT, KMB, MJN and CRI which may be impacted and discussed on the Analyst/Industry conference call to be held on May 23 at 10 am. |
|
| May 22, 2013 |
| 07:28 EDT | | ABT | UBS to host a conference
Global Healthcare Services Conference is being held in New York on May 20-22 with webcasted company presentations to begin on May 22 at 8 am; not all company presentations may be webcasted. Webcast Link |
|
| May 21, 2013 |
| 08:03 EDT |  | ABT | Abbott announces CE Mark for coronary drug eluting stent
 Subscribe for More Information |
|
| May 20, 2013 |
| 10:11 EDT |  | ABT | On The Fly: Analyst Upgrade Summary
Subscribe for More Information |
|
| 06:01 EDT | | ABT | Abbott upgraded to Buy from Neutral at Goldman
Goldman upgraded Abbott to reflect accelerating growth driven by emerging markets, better growth and product mix, new product launches, and market share gains. Price target raised to $44 from $38. |
|
| May 9, 2013 |
| 07:04 EDT | | ABT | Abbott announces CE Mark for A1c test
Subscribe for More Information |
|
|
|
|
|
